SCHEMBL27508685

SCHEMBL27508685

Cc1cc([N+](=O)[O-])cc(C(F)(F)F)c1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.45
CYP3A4 P08684 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
HTT P42858 2/20 0.43
GALR3 O60755 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TSHR P16473 3/20 0.43
GPR35 Q9HC97 1/20 0.42
CYP1A2 P05177 2/20 0.40
PDE7A Q13946 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPT P10636 1/20 0.37
PKM P14618 1/20 0.37
POLB P06746 1/20 0.37
CYP19A1 P11511 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15271018 0.87 ALDH1A1 (0.47) ALDH1A1CYP3A4TDP1MEN1KMT2A
SCHEMBL9944130 0.83 ALDH1A1 (0.46) ALDH1A1CYP3A4TDP1MEN1KMT2A
SCHEMBL28588307 0.82 ALDH1A1 (0.46) ALDH1A1CYP3A4MEN1KMT2AHTT
SCHEMBL2659395 0.81 ALDH1A1 (0.57) ALDH1A1CYP3A4TDP1MEN1KMT2A
SCHEMBL28256008 0.81 ALDH1A1 (0.61) ALDH1A1CYP3A4TDP1MEN1KMT2A
SCHEMBL28375616 0.81 ALDH1A1 (0.49) ALDH1A1CYP3A4TDP1MEN1KMT2A
SCHEMBL27455048 0.81 ALDH1A1 (0.46) ALDH1A1CYP3A4TDP1MEN1KMT2A
SCHEMBL16451131 0.80 ALDH1A1 (0.51) ALDH1A1TDP1MEN1KMT2AHTT
SCHEMBL28916197 0.79 ALDH1A1 (0.50) ALDH1A1CYP3A4TDP1MEN1KMT2A
SCHEMBL29945744 0.79 ALDH1A1 (0.45) ALDH1A1CYP3A4TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101337895-B Method for preparing 2,2'-di(trifluoromethyl)-4,4'-benzidine WUYI TIANDA PREC CHEMICAL HIGH NEW TECHNOLOGY DEV CT 2011-05-11 CN claimed
CN-101337895-A Method for preparing 2,2'-di(trifluoromethyl)-4,4'-benzidine WUYI TIANDA PREC CHEMICAL HIGH (CN) 2009-01-07 CN claimed
CN-101337892-A Method for preparing 2-brom-5-nitrobenzotrifluoride WUYI TIANDA PREC CHEMICAL HIGH (CN) 2009-01-07 CN claimed
CN-106316864-A Preparation method of 4-methyl-3-trifluoromethyl phenylamine 苏州天马精细化学品股份有限公司 2017-01-11 CN disclosed
CN-101337895-B Method for preparing 2,2'-di(trifluoromethyl)-4,4'-benzidine WUYI TIANDA PREC CHEMICAL HIGH NEW TECHNOLOGY DEV CT 2011-05-11 CN disclosed
CN-101337895-A Method for preparing 2,2'-di(trifluoromethyl)-4,4'-benzidine WUYI TIANDA PREC CHEMICAL HIGH (CN) 2009-01-07 CN disclosed
CN-101337892-A Method for preparing 2-brom-5-nitrobenzotrifluoride WUYI TIANDA PREC CHEMICAL HIGH (CN) 2009-01-07 CN disclosed
CN-100427483-C Anthranilic acid amide derivatives and their pharmaceutical use NOVARTIS AG (CH) 2008-10-22 CN disclosed
CN-101198607-A Phenylacetamides suitable as protein kinase inhibitors NOVARTIS AG (CH) 2008-06-11 CN disclosed
CN-101045727-A Inhibitors of tyrosine kinases NOVARTIS AG (CH) 2007-10-03 CN disclosed
CN-1324022-C Tyrosine kinase inhibitors NOVARTIS AG (CH) 2007-07-04 CN disclosed
CN-1279026-C Prostaglandin endoperoxide H synthase biosynthesis inhibitors ABBOTT LAB (US) 2006-10-11 CN disclosed
CN-1720244-A Anthranilic acid amide derivatives and their pharmaceutical use NOVARTIS AG (CH) 2006-01-11 CN disclosed
CN-1675195-A Tyrosine kinase inhibitors NOVARTIS AG (CH) 2005-09-28 CN disclosed
CN-1167687-C Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors ���Ͽع����޹�˾ 2004-09-22 CN disclosed
CN-1342149-A Prostaglandin endoperoxide H synthase biosynthesis inhibitors ABBOTT LAB (US) 2002-03-27 CN disclosed
CN-1277605-A Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors ABBOTT LAB (US) 2000-12-20 CN disclosed